SennaLax-S is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Par Pharmaceutical. The primary component is Docusate Sodium; Sennosides.
| Product ID | 0603-0283_8ae458b5-3454-4c80-89b3-fbb6773d06e6 |
| NDC | 0603-0283 |
| Product Type | Human Otc Drug |
| Proprietary Name | SennaLax-S |
| Generic Name | Senna And Docusate Sodium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2007-07-26 |
| Marketing End Date | 2020-06-30 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | Par Pharmaceutical |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Marketing Start Date | 2007-07-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-07-26 |
| Marketing End Date | 2020-05-30 |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-07-26 |
| Marketing End Date | 2020-06-30 |
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SPL SET ID: | 7f029a23-a54f-40bb-8b8f-6bba2ab47db0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0603-0283 | SennaLax-S | senna and docusate sodium |
| 55700-365 | SennaLax-S | senna and docusate sodium |
| 68788-0848 | SennaLax-S | senna and docusate sodium |
| 0603-0149 | DocQLax | senna and docusate sodium |
| 11534-090 | Senna and Docusate Sodium | Senna and Docusate Sodium |
| 11534-134 | Senna and Docusate Sodium | Senna and Docusate Sodium |